✦ LIBER ✦

Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas : The St. Jude children's research hospital experience

✍ Scribed by Fariba Navid; Victor M. Santana; Catherine A. Billups; Thomas E. Merchant; Wayne L. Furman; Sheri L. Spunt; Alvida M. Cain; Bhaskar N. Rao; Gregory A. Hale; Alberto S. Pappo

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 111 KB
Volume: 106
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21810

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High histologic and overall response to

High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk ewing sarcoma family tumors : The Bambino Gesù Children's Hospital experience

✍ Giuseppe Maria Milano; Raffaele Cozza; Ilaria Ilari; Luigi De Sio; Renata Boldri 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

Erratum: Milano GM, Cozza R, Ilari I, et

Erratum: Milano GM, Cozza R, Ilari I, et al. High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk ewing sarcoma family tumors: The Bambino Gesù Children's Hospital experience. Cancer. 2006;106(8):1838–45.

📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 24 KB 👁 1 views